Moreover, in terms of molecular targets for treatment, hyper active mTORC1 may offer an explicit target for an all-in-one treatment of T2D
Moreover, in terms of molecular targets for treatment, hyper active mTORC1 may offer an explicit target for an all-in-one treatment of T2D. non-glycemic diseases of T2D may have contributed to T2D being still an unmet need. An mTORC1-centric paradigm maintains that hyperactive mTORC1 drives the glycemic and non-glycemic disease aspects of T2D. Hyperactive mTORC1 is… Read More: Moreover, in terms of molecular targets for treatment, hyper active… »